首页|期刊导航|药物分析学报(英文)|Exploring TGFBR3 in disease pathogenesis:Mechanisms,clinical implications,and pharmacological modulation

Exploring TGFBR3 in disease pathogenesis:Mechanisms,clinical implications,and pharmacological modulationOA

Exploring TGFBR3 in disease pathogenesis:Mechanisms,clinical implications,and pharmacological modulation

Hui Song;Jinjiang Chou;Peng Zhao;Meijun Chen;Jue Yang;Xiaojiang Hao

Key Laboratory of Endemic and Ethnic Diseases,Ministry of Education & State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine,Guizhou Medical University,Guiyang,550004,China||Key Laboratory of Medical Molecular Biology of Guizhou Province,Guiyang,550004,ChinaDepartment of Cell and Molecular Biology,Karolinska Institutet,Stockholm,17165,SwedenKey Laboratory of Endemic and Ethnic Diseases,Ministry of Education & State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine,Guizhou Medical University,Guiyang,550004,China||Natural Products Research Center of Guizhou Province,Guiyang,550014,ChinaKey Laboratory of Endemic and Ethnic Diseases,Ministry of Education & State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine,Guizhou Medical University,Guiyang,550004,China||Natural Products Research Center of Guizhou Province,Guiyang,550014,ChinaKey Laboratory of Endemic and Ethnic Diseases,Ministry of Education & State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine,Guizhou Medical University,Guiyang,550004,China||Natural Products Research Center of Guizhou Province,Guiyang,550014,ChinaKey Laboratory of Endemic and Ethnic Diseases,Ministry of Education & State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine,Guizhou Medical University,Guiyang,550004,China||Natural Products Research Center of Guizhou Province,Guiyang,550014,China

TGFBR3CancerDiabetesEpigenetic modificationsPharmaceutical interventions

TGFBR3CancerDiabetesEpigenetic modificationsPharmaceutical interventions

《药物分析学报(英文)》 2026 (3)

598-614,17

This study was funded by grants from the National Natural Science Foundation of China(Grant Nos.:82304348,82160813,and 32060210),2022 Guiyang Science and Technology Talent Training Project(Project No.:[2023]48-5),Guizhou Science and Technology Innovation Talent Team(Grant No.:QKHPTRC-CXTD[2022]007),and Guizhou Medical University(Grant No.:[2024]011).

10.1016/j.jpha.2025.101372

评论